STEVAN HENSON: Open Payments
NPI 1497301915 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$56 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $56
Food & beverage: $56
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: CAPLYTA, REXULTI, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
